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Summary 
Mutations in the Bruton’s tyrosine kinase (Bfk) gene 
have been linked to severe early B cell developmental 
blocks in human X-linked agammaglobulinemia (XLA), 
and to milder B cell activation deficiencies in murine 
X-linked immune deficiency (X&f). To elucidate un- 
equivocally potential Btk functions in mice, we gener- 
ated mutations in embryonic stem cells, which elimi- 
nated the ability to encode Btk pleckstrin homology 
or kinase domains, and assayed their effects by RAGP- 
deficient blastocyst complementatlon or introduction 
into the germline. Both mutations block expression of 
Btk protein and lead to reduced numbers of mature 
conventional B cells, severe Bl cell deficiency, serum 
IgM and lgG3 deficiency, and defective responses in 
vitro to various B cell activators and in vivo to immu- 
nization with thymus-independent type II antigens. 
These results prove that lack of Btk function results 
in an Xid phenotype and further suggest a differential 
requirement for Btk during the early stages of murine 
versus human B lymphocyte development. 
Introduction 
X-linked agammaglobulinaemia (XLA) is an inherited X 
chromosome-linked humoral immunodeficiency disease 
(Bruton, 1952). Afflicted males have a severe deficiency 
of mature B cells and circulating immunoglobulins of all 
isotypes. The XLA defect is intrinsic to the B lineage (Con- 
ley et al., 1986) and is manifested at several stages of B 
cell development. An early developmental block is evi- 
IlThese authors contributed equally to this study. 
dented by an increase in pro-B cells and inefficient expan- 
sion and proliferation of preB cells in the bone marrow 
(BM) (Pearl et al., 1978; Campana et al., 1990; Milili et 
al., 1993). There is also a severe deficiency of peripheral 
B cells due to a block in development at the pre-B stage; 
peripheral B cells that are present usually have an im- 
mature, (immunoglobulin Mhi [IgM”‘]/IgD”) phenotype (re- 
viewed by Rosen et al., 1984; Conley, 1985; Cooper et 
al., 1993). 
Murine X-linked immunodeficiency (Xid, Amsbaugh et 
al., 1972; Scher et al., 1975, 1979) shares many features 
with human XLA. Like XLA, the Xid defect (reviewed by 
Scher, 1982) is X-linked and intrinsic to B cells. In CBA/N 
(Xid) mice, the overall number of peripheral B cells is usu- 
ally 500/b-60% of normal (Scher et al., 1975; Janeway and 
Barthold, 1975); in addition, the IgMYIgDhi B cell popula- 
tion (population 1) in the spleen is severely reduced (Hardy 
et al., 1982, 1983; Forrester et al., 1987) CD5’ B cells 
(Bl cells) are not detected (Hayakawa et al., 1986), and 
levels of serum IgM and lgG3 are low (Perlmutter et al., 
1979). Furthermore, Xid mice are unable to respond to 
thymus-independent type II (TI-II) antigens (Scher et al., 
1975; Amsbaugh et al., 1972) and to some thymus- 
dependent (TD) antigens (Boswell et al., 1980; Press, 
1981; Press and Giorgetti, 1986). In vitro studies also have 
shown that Xid B cells do not proliferate when triggered 
through their surface IgM receptor (Mond, 1982; Rigley 
et al., 1989) and show hyporeactivity to lipopolysaccharide 
(LPS) stimulation (Amsbaugh et al., 1972; Huber and 
Melchers, 1979). 
A recently identified X-linked gene that encodes a cyto- 
plasmic tyrosine kinase, denoted Bruton’s tyrosine kinase 
(Btk), has been shown to be mutated in humans with XLA 
(Vetrie et al., 1993; Tsukada et al., 1993) and mice with 
Xid(Thomas et al., 1993; Rawlings et al., 1993) mutations. 
Btk, along with Tee (Mano et al., 1993) and Itk (Siliciano 
et al., 1992), comprise the TeclBtk subfamily of Src-related 
tyrosine kinases. Btk contains src homology (SH) do- 
mains, including the SHl (kinase), SH2, and SH3 domains 
(reviewed by Pawson and Gish, 1992); a unique N-terminal 
region, which is comprised of a pleckstrin homology (PH) 
domain (Clark and Baltimore, 1993; Haslam et al., 1993; 
Mayers et al., 1993; Musacchio et al., 1993; Shaw, 1993); 
and a Tee homology (TH) domain (Vihinen et al., 1994) 
(Figure 1). The PH domains have been found in many 
proteins involved in intracellular signaling pathways and, 
although of unknown function, have been speculated to 
be involved in protein-protein interactions. Likewise, the 
function of the TH domain is unknown. Unlike the Src 
protein, Btk protein lacks a negative regulatory tyrosine 
residue at the C terminus and a myristylation signal for 
membrane anchoring at the N terminus (reviewed by Mus- 
telin and Burn, 1993). 
Btk is expressed in B lymphocytes as well as in myeloid 
and erythroid cells. The gene is expressed in most stages 
of B cell development, except the terminally differentiated 
plasma cell stage (de Weers et al., 1993; Smith et al., 
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Figure 1. Disruption of Murine St& Gene 
(A) Physical map of the St/r locus (lop). Exons 
are represented by boxes. Targeting vector for 
PH domain knockout and predicted structure 
of the mutated locus (bottom left). Targeting 
vector for kinase domain knockout and pre- 
dicted structure of the mutated locus after 
homologous recombination (bottom right). 
Probes and expected sizes of DNA fragments 
from the endogenous and after homologous re- 
combination are shown. TK; thymidine kinase 
gene; Neo, neomycin resistance gene. Restric- 
tion endonucleases: 6, BarnHI; R, EcoRI; H, 
Hindlll; S, Sack and P, Pstl. 
(6) Contribution of the PH- ES cells to lymphoid 
tissues as indicated in PH-IRAG2” somatic 
chimeric mouse. DNA (IO pg) was digested 
with Hindlll and assayed for hybridization to a 
700 bp Pvull fragment shown in (A) (bottom 
left). The endogenous locus gave a band of 
about 12.0 kb and the mutant locus gives a 
band of about 9.0 kb. Male ES cells were used 
in which, due to X chromosome linkage of Btk, 
only a single targeting event was necessary to 
get inactivation of Bfk for injection in RAG2- 
deficient blastocyst complementation system. 
(C) Contribution of the kinase-negative ES cells to lymphoid tissues, as indicated, in St/r-Kin-/flAGP-‘- somatic chimeric mouse. DNA (10 ug) was 
digested with EcoRl and assayed for hybridization to the 700 bp SamHI-Hindlll fragment shown in (A) (bottom right). The endogenous locus gave 
a band of about 7.0 kb and the mutant locus gives a band of about 6.5 kb. Male ES cells were used in which, owing to X chromosome linkage 
of St/r, only a single targeting event was necessary to get inactivation of Btk for injection in RAGP-deficient blastocyst complementation system. 
(D) Germline transmission of the Btk kinase mutation analyzed by Southern blotting of mouse tail DNA. DNA was digested with EcoRI, separated 
in a 0.7% agarose gel bloted to a zeta probe membrane, and hybridized with random-primed 32P-labeled SamHI-Hindlll 700 bp DNA fragment 
shown in (A) (bottom riaht). From left, DNA from a normal littermate male (WV) (used as a wild-type w] control), two Btk-kin-‘+ heterozygous 
(X/XT femaieb and a &-kin- (XW) male are shown. 
1994; Khan et al., 1995). The pattern of Btk expression 
coupled with the defects observed in the context of the 
XLA and Xid mutations, led to the notion that Btk may 
serve critical signaling functions at various stages of B 
cell development. In this context, a number of recent stud- 
ies have suggested a potential function for Btk in signaling 
from the pre-6 cell receptor and from the mature B cell 
receptor (Saouf et al., 1994; Aoki et al., 1994) as well as 
in the response of 6 cells to stimulation via the CD40, 
interleukind (IL+), IL-lo, and CD38 pathways (Hasbold 
and Klaus, 1994; Go et al., 1990; Sat0 et al., 1994; Santos- 
Argumendo et al., 1995). 
Mutational analyses of Bfk in XLA patients to date have 
not been helpful in correlating different domains to func- 
tion. XLA patients carry mutations in the Btk gene that 
include deletions, insertions, and point mutations leading 
to amino acid substitutions or premature stop codons in 
virtually all the domains (reviewed by Sideras and Smith, 
1995). However, most patients show the typical severe 
XLA phenotype outlined above. The putative murine Xid 
mutation involves a single amino acid substitution of a 
highly conserved residue in the PH domain (Thomas et 
al., 1993; Rawlings et al., 1993). However, a different sub- 
stitution mutation of the same amino acid residue mutated 
in Xid mice was found to be associated with the severe 
XLA phenotype in humans (de Weers et al., 1994). In this 
context, the Xid mutation also leads to a severe block in 
B cell development when introduced into the homozygous 
nude (nu-/nu-) background (Karagogeos et al., 1986). 
Likewise, within families of XLA patients, the disease phe- 
notype can be highly variable in severity (reviewed by Ro- 
sen et al., 1984). Together, these findings suggest that 
other factors may greatly influence the phenotype of Btk 
mutations. 
There are several proposed explanations for the milder 
phenotype of the murine Xid as compared with the human 
XLA mutations, assuming that both involve only the Bfk 
gene. One is that the function affected by the Xidmutation 
would only interfere with Btk activities required at later 
stages in the context of some forms of B cell activation, 
whereas more severe inactivation of the Btk protein in XLA 
could block a required function in early B cell development 
(Thomas et al., 1993; Rawlings et al., 1993). Other possibil- 
ities suggested from the apparently differential effects of 
similar mutations in Xid and certain cases of XLA, are that 
mice have a redundant signaling pathway in early B cell 
development, or that genetic background may have a ma- 
jor influence on the phenotypic severity of Btk mutations, 
or both. 
In this report, we describe the use of gene-targeted mu- 
tation in embryonic stem (ES) cells to elucidate the essen- 
tial roles of Btk in B cell maturation and function, to distin- 
guish the various models proposed to explain differences 
in XLA andxidphenotypes, and to establish a Btk-deficient 
mouse model. 
Results 
Generation of PH and Kinase Domain Bfk Mutations 
in ES Cells and Mice 
The BNC genomic locus is encoded by 19 exons (Sideras 
et al., 1995; Figure 1 A). There are four potential translation 
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initiation codons in exons 2, 4, 6, and 7, which upon in 
vitro translation give proteins of 77, 66, 58, and 50 kDas. 
However, only the 77 kDa protein starting at the first ATG 
is detectable in vivo (Tsukada et al., 1993). We introduced 
two separate mutations into the Btk gene. For the first, 
we replaced, in CCE ES cells, the first two coding exons 
(which encode 80 of the 117 aa of the PH domain) with 
a neomycin resistance (neol) gene (Figure 1 A, left, Btk- 
PH- mutation; Figure 16). This mutation deletes the first 
translation initiation codon in exon 2 and should either 
permit generation of a truncated Btk protein without a PH 
domain or should completely ablate synthesis of the Btk 
protein. For the second mutation, we replaced, in Jl ES 
cells, exons 13 and 14 (which encode the first two exons 
of the kinase domain) with a near gene (Figure lA, right, 
Btk-kin-; Figure 1C). The latter mutation disrupts the Btk 
open reading frame by introducing a stopcodon that inacti- 
vates the entire C-terminal coding region. 
There is only one copy of the Btk gene in the male- 
derived CCE and Jl ES cells. Thus, Btk-PH- ES cells 
were directly used to generate chimeras by injection into 
recombination activating gene-2 (RAGP)-deficient blasto- 
cysts. RAGP-deficient mice lack mature lymphocytes due 
to their inability to initiate VDJ recombination (Shinkai et 
al., 1992); therefore, all the mature lymphocytes in chime- 
ric mice are mutant ES cell derived (Chen et al., 1993). The 
Btk-kin- ES cells were similarly used to generate somatic 
chimeras in RAGP-deficient blastocyst complementation 
system. In addition, to compare results obtained for lym- 
phocyte-intrinsic versus germline mutations, the Btk-kin- 
mutation was also introduced into the mouse germline 
(Btk-kin-IGL) (Figure 1 D). 
Lack of Btk Expression in PH and 
Kinase Domain Mutant B Cells 
As assayed by RAGP-deficient blastocyst complementa- 
tion (Btk-PH- or Btk-kin- mutations) or germline transmis- 
sion (Btk-kin-IGL), neither Btk mutation had an obvious 
effect on T cell development and population distribution 
(Tables 1, 2, 3; data not shown). Contribution of Btk-PH- 
and Btk-kin- ES cells to mature lymphocytes generated by 
RAGP-deficient blastocyst complementation was further 
confirmed by Southern blot analysis, which demonstrated 
nearly full contribution of the mutant allele to thymic DNA 
(Figures 1B and 1C). Likewise, neither mutation led to 
severe blocks in the generation of conventional B cells in 
this system, although both had similar effects on B cell 
development and function (see below). 
To confirm the predicted effects of the introduced muta- 
tions on Btk gene expression, we assayed for potential 
Btk transcripts and proteins in both splenic B cells and 
A-MuLV transformed pre-B cells carrying each respective 
mutation. In Btk-PH- B cells, Btk-specific transcripts from 
the mutated loci weredetectable by Northern blotting anal- 
yses (Figure 2A). These transcripts hybridized to probes 
derived both from the 5’ and 3’ ends of the Btk cDNA but 
not to the neo’ gene probe (Figure 2A). As the predicted 
size of the Btk-PH- transcripts is not substantially different 
from that of wild type, we cloned BtkcDNA from Btk-PH- B 
cells by reverse transcription-polymerase chain reaction 
(PCR), utilizing primers in exons 1 and 6. PCR products 
of the expected size (Figure 28, right, 600 bp) in the normal 
and Btk-kin- B cells could be seen (Figure 28, left). Also, 
an expected reduced-size PCR product, resulting from de- 
letion of exons 2 and 3, was detected in Btk-PH- B cells 
(Figure 28, right, 340 bp). The nucleotide sequence of 
the PCR products was determined through the regions 
containing the PH and TH domains. Exon 1 was found 
spliced correctly to exon 4, deleting the intraintronic neb 
gene, which was inserted by gene targeting (data not 
shown). Northern blot analyses of RNA from Btk-kin- 
A-MuLV-transformed lines revealed a larger low abun- 
dance transcript that hybridized to 5’ end and 3’ end frag- 
ments of Btk cDNA and to the neo’ gene probes (Figure 
2A), indicating that Btk-specific transcripts from the mu- 
tated locus were generated in which Btk sequences both 
5’ and 3’to the insertion were fused to the neo’ gene (Fig- 
ure 2A). 
To assay for Btk protein production, Western blotting 
experiments were performed on extracts from normal and 
mutant A-MuLV transformants with affinity-purified anti- 
bodies raised against the C-terminal region or N-terminal 
region of Btk. The normal Btk gene encodes a 77 kDa 
protein, which is readily detectable in extracts from a 
RAGI’- A-MuLV transformant (Figure 2C). The anti-C ter- 
minus anti-sera should also detect potential truncated pro- 
teins generated by utilizing the second or third ATGs in 
the Btk gene. However, no Btk protein of normal or re- 
duced size was detected in extracts from Btk-PH- A-MuLV 
transformants (Figure 2C), indicating that the truncated 
transcript detected in these lines either is not translated 
from these ATGs or that the resulting proteins are highly 
unstable. Likewise, no Btk protein was detected by this 
method in &k-Kin- A-MuLV transformants, although this 
does not rule out presence of a truncated protein that lacks 
the C terminus. Therefore, to investigate whether a trun- 
cated protein is synthesized from the Btk-kin- locus, anti- 
N-terminal antibodies raised against GST-PH/TH fusion 
proteins were employed in immunoprecipitation experi- 
ments with extracts from %-labeled &k-kin- A-MuLV- 
transformed cells. However, Btk protein was not detected 
in the extracts from Btk-kin- cells by this method from the 
Btk-kin- allele (Figure 2D). 
Flow Cytometric Analysis of Lymphocytes 
from Btk and Xid Mice 
B lineage cells in the BM can be identified by the expres- 
sion of the B220 surface antigen. Subpopulations repre- 
senting different stages of early B cell development can 
be further distinguished on the basis of expression of addi- 
tional surface markers (Hardy et al., 1991). The normal 
BM contains B220%D43+ pro-B cells, B22O+/CD43- pre-B 
cells, B220+/lgM+ newly generated B cells, and B220h’/ 
IgM+/IgD+ B cells that are mostly recirculating B cells from 
the periphery (Kantor et al., 1995; Allman et al., 1992, 
1993). Flow cytometric analyses for the expression of 
these markers clearly demonstrated the presence of the 
pro-B, pre-B, and newly generated surface immunoglobu- 
lin-positive B cell subsets in the BM of Btk-PH-IRAGY 
and &k-Kin-IRAGP-‘- chimeric mice. However, there ap- 
peared to be a small increase in relative size of the 8220’1 
CD43+ pro-B cell population compared with 129Sv mice, 
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Figure 2. Btk mRNA and Protein Analyses from Brk-PH- and St/r- 
&in- Targeted Loci 
(A) Northern blot analysis of cytoplasmic RNA from Btk-PH-, /St/r-kin-, 
and the RAG2-I- A-MuLV cell line 63-12 (indicated as control). Total 
cytoplasmic RNA (lo-30 ug) was electrophoresed in formaldehyde 
agarose gel and transfered to zeta probe membrane and hybridized 
with a S-end 1.4 kb EcoRl Btk murine cDNA fragment (top left), a 3’-end 
1.5 kb EcoRl Btk murine cDNA fragment (top middle), and neomycin 
resistance gene fragment (Pst-Pst 600 bp) (top right). For comparison 
of RNA quantities in different lanes, the blots were stripped and rehy- 
brized to a GAPDH probe (bottom). 
(6) Structure of the Et/r-PH- transcript. In Btk-PH- B cells, a smaller 
(340 bp) PCR product was detected due to deletion of exons 2 and 
3. RT-PCR was performed on RNA from purified B cells of Brk-PH., 
B&kin-, and normal mice; T cells were used as negative control. 
Position of primers and expected fragment sizes are depicted in the 
cartoon (top left). PCR products were electrophoresed in a 1.2% aga- 
rose gel and stained with ethidium bromide. 
(C) Western blot analysis of Brk-PH- A-MuLV cell lines. Lysates from 
approximately 10 x 1 OBcells were electrophoresed in 8% SDS-PAGE 
and transfered to immobilon membrane and allowed to react with im- 
munoaffinity-purified anti-Btk raised against the C terminus. The anti- 
bodies bound tofilterwere detected by second antibody and chemileu- 
miniscene detection system. Mobility of the molecular weight markers 
is shown on the right side of the blot. 
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(D) lmmunoprecipitation and 
SDS-PAGE analysis of Btk- 
Kin- A-MuLV cell line. Ly- 
sates from approximately 10 x 
10e[35S]methlonine/cysteine- 
labeled cells were subjected to 
immunoprecipitation with anti- 
bodies to the N terminus of Btk, 
eluates were electrophoresed 
in 8% SDS-PAGE and exposed 
to X-ray film for 5 hr. RAGZ-‘- 
cell line, 63-12, was used as 
positive control and T cell line, 
DOlO, was used as negative 
control. To detect any small 
quantities of truncated protein 
as indicated by weak signal in 
Northern analysis or due to in- 
stability of the truncated protein 
for Btk-kin- cell line, we used 
extractfrom 30 x 1Qcells. The 
bands seen in the Btk-kin- 
A-MuLV cell line were also visi- 
ble in positive control upon 
longer exposure and therefore 
represent nonspecific back- 
ground. Mobility of the molecu- 
lar weight markers is shown on 
the right side of the auto- 
radiogram. 
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Figure 3. Flow Cytometric Analysis of B- to IO-week-old Bf/+PH~/f?AG2-‘- and Bfk-Kin-/RAG2-‘- Chimeric Mice, RAGP“-, and 129Bv Mice 
Dot plots after excluding dead cells (propidium iodide-bright) are displayed. 
(A) Early B lineage lymphocytes reperesenting different stages of maturation (Hardy et al., 1991) in the BM were analyzed by double staining with 
PE-B220 and FITC-CD43. 
(B) Mature B lymphocytes in the BM were revealed by staining with PE-IgM and FITC-8220. 
(C) B lymphcytes in the spleen were analyzed by double staining with PE-anti-IgM and FITC-antLB220. 
(D) Three populations of B lymphocytes expressing different levels of IgM and IgD expression, IgMVIgD”’ (population I), IgMhN/lgD”’ (population 
2), and IgMVIgD” (population 3) cells in the spleen were revealed by double staining with PE-anti-IgM and FITC-anti-IgD. 
(E) IgM+ and CD5+ @la) B lymphocytes in peritoneal cavity were analyzed by double staining with PE-anti-CD5 and FITC-anti-IgM. Dot plots of 
lymphocytes gated by forward scatter and side scatter are displayed. 
which were used as normal control (Figure 3A). Since B 
cell development in the BM of RAGP-‘- mice is blocked at 
the B220+/CD43+ pro-B cell stage (Shinkai et al., 1992), 
the apparent increase in the size of the pro-B population 
in Btk-PH-/RAG2+ and Btk-Kin-IRAGP-‘- chimeric BM is 
difficult to interpret unequivocally but was further resolved 
by analyses of germline Btk-kin- mutant mice (see below). 
To investigate the effect of St/r-PH- and Btk-kin- muta- 
tions on the peripheral B cell compartment, comparative 
flow cytometric analyses were performed on splenocytes 
of R/r-PH-/RAGP+ and Btk-kin-/RAG2-‘- chimeric mice 
(Figure 3C). Compared with normal mice, the two Btk mu- 
tant chimeras exhibited fewer IgM+ B cells (60%-70% of 
control) as well as a decrease in the IgMYlgDhi mature B 
cells (Figure 3D). A substantial number of B cells present 
in the peritoneal cavity of normal mice are Bl B cells. A 
subset of Bl cells, Bla cells, can be distinguished from 
conventional (82) IgM+ B cells by their expression of CD5 
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Figure 4. Flow Cytometric Analysis of a Normal Littermate Mouse (St/r-kin+‘, Sibling of a Etk-kin-” Mouse), a BUr-kin’” Mutant, and a Xid (CBA/N 
XaldY) Mouse Are Compared 
The mice shown are representative of the mice examined. 
(A) BM cell suspensions from 9- to IBweek-old mice were stained with CD43/S7(PE), 8220/682(APC), and lgMKW(FITC). IgM+ cells, as well as 
dead cells (propidium iodide-bright) and high obtuse scatter cells, are excluded by software gating (29%-310/b of the total cells collected). The 
percent of B220+, IgM cells that are 8220’ and CD43’ and the percent of 8220’. IgM- and CD43- cells is indicated. The ratio of IgM, 8220’ cells 
that are CD43- to IgM-, 6220’ CD43’ cells is shown. 
(B) EM cell suspensions from lo- to 13-week-old mice were stained with CD43/S7(PE), B220/662(APC), and IgM/331(TR-AV). CD43- ceils are 
displayed (29%-33% of total cells; dead cells and high obtuse scatter were also excluded). The percent of cells displayed that fall within fraction 
D, fraction E, and fraction F (as described by Hardy et al., 1991) are indicated. Because fractions E, F, (and a small population of 6226bright, 
IgM-bright cells that are not included in either fraction) are not well resolved, it is likely that (especially for the Bfk-kin- and xid mice) the percentages 
indicated for fraction F may be an overestimation of this population. 
(C) Spleen cell suspensions from lo- to 13-week-old mice were stained with IgDll I-26(TR-AV), lgM/331(FITC), and B220/6B2(APC) (20%-23% 
of the cells were excluded as dead or high obtuse scatter). The percent of cells displayed that are 8220’ is indicated. 
(D) 8220’ cells from the above samples (C) are displayed. The percent of cells displayed that are IgD+ and IgMb (population I), IgD+ and IgM+ 
(population 2) or IgD’” and IgM’ (population 3) (Hardy et al., 1982, 1983) is indicated. 
(E) Cell suspensions from peritoneal washes from 19to 19weekold mice were stained with lgMKGl(FITC) and CD5/53-7(APC). After excluding 
cells by propidum iodide stain and obtuse and forward scatter, 42% of cells from the normal mouse are displayed in this panel, 13.2 % from the 
knockout, and 10.8% from the xid. 
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(Herzenberg et al., 1986; Herzenberg and Kantor, 1993). 
Notably, the Btk-PH-/RAG? and Btk-kin-IRAGP-‘- ap- 
peared to lack Bla (CD5+) cells in their peritoneum and 
have reduced numbers of conventional B cells (Figure 3E). 
The RAG2deficient blastocyst complementation method 
examines only the consequence of lymphocyte-intrinsic 
defects, as other cell types can be variably contributed by 
the host blastocyst. As Btk is known to be expressed at 
low levels in other cell types, we considered the possibility 
that a more marked phenotype, such as that observed in 
typical XLA cases, might arise as a result of complete 
ablation of Btk expression in all cell lineages. Therefore, 
we determined the affects of the Btk-kin- mutation after 
introduction into the mouse germline. Mutant males and 
homozygous mutant females had identical phenotypes, 
which were similar to the aberrations in BM and peripheral 
B cell populations observed by ffAG2-deficient blasto- 
cyst complementation. These abnormalities included de- 
creased numbers of peripheral splenic B cells, decreased 
numbersof IgM’VIgDhisplenic B cells, decreased numbers 
of peritoneal B cells, substantial diminution of Bl cells, 
and no apparent defects outside of the B lineage (Figure 
4; Tables 1, 2, 3; data not shown). 
Examination of germline Btk-kin- mutant mice (Btk- 
kin-IGL) allowed us to assess the potential affects of this 
mutation on early B cell development in the BM in more 
detail. We clearly observed an increase in the size of the 
pro-B (B220VCD43’) cell population in both Btk-kin-IGL 
and xid mice as compared with normal mice (Figure 4A; 
Table 1, legend). The pro-B cell compartment can be sub- 
divided into three subfractions (A, B, and C), representing 
increasing levels of maturation (Hardy et al., 1991). Analy- 
sis of the relative proportionsof these fractions in the pro-B 
compartment of Btk-kin-IGL mice revealed no obvious 
differences from the distribution observed in normal ani- 
mals(datanot shown). Finally, asobserved with bothtypes 
of RAG2deficient chimeras, both Btk-kin-IGL and CBA/N 
mice showed a markedly reduced population of B220h’l 
IgM+/IgD+ recirculating mature B cells (fraction F) (see Fig- 
ure 38; Figure 48; Tables 1, 2, 3; data not shown). 
The B cell populations in the periphery of B&PH-I 
RAGP-‘- and Btk-kin-IRAGP-‘- and Btk-kin-IGL mice ap- 
peared to be very similar to that previously described for 
CBA/N (Xid) mice (Scher et al., 1975; Hardy et al., 1982, 
1963; Hayakawa et al., 1986; Figure 4; Tables 1, 2, 3). In 
the BM, Btk-deficient mice, like Xid mice, have, at most, a 
modest early developmental arrest in B cell development. 
St&Deficient Mice Have Reduced Levels 
of Serum lmmunoglobulins 
Serum levels of all immunoglobulin isotypes were deter- 
mined by enzyme-linked immunosorbent assay (ELISA) 
in Btk-PH-/RAG2-‘- and Btk-kin- germline mutants and 
compared with those of normal littermates, CBA.XidIHHW 
(Wortis et al., 1982) and CBA/CaHN-XidlJ (Jackson Labo- 
ratories) mice ranging in age from 8 weeks to 6 months 
in age. All of the mutant mice had severely decreased 
levels of IgM and lgG3 (Figure 5); in addition, the Btk- 
kin-IGL, Rk-PH-IRAGP-‘- chimeric and the Xid mice had 
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Table 2. Frequencies of Lymphocyte Populations in Brk-kin- Mice, CBA/N.xid, and C57BU6.xid 
Spleen Total S Cells (6220+) Total IgM+ cells CD4+ T cells0 
Type of Number Recovered cells Number Number Number 
mouse of mice in millions Percent (roe) Percent (106J Percent W) 
CD6+ T ceIlsa 
Number 
Percent (JOB) 
Wild type 17 67 f 34 43 2 11 37 * 17 37 f. 10 32 f 15 16 f 3.3 16 f 5.6 12 f 1.7 11 f 3.4 
Btk knockout 8 59 r 27 35 f 10 22 f 16 29 f 4.7 18 f 8.6 19 f 1.8 14 f 5.7 13 f 2.8 9.2 f 3.4 
xid 9 34 f 13 33e9.0 1124 31 f 8.6 IO f 3.7 24 2 2.2 8.4 + 3.2 14 f 2.8 4.6 f 1.2 
86.xid 7 96 f 29 43+14 41+19 46k3.7 44+13 15 f 1.8 14 f 5.3 9.3 rt 1.8 8.7 + 2.6 
See legend to Table 1. 
a Wild-type mice (11) and seven Btk-/dnmn 
relatively decreased, but variable levels of IgGl , IgGPa, 
IgG2b, and IgA isotypes (Figure 5). Notably, the deficiency 
of all isotypes was even more pronounced in the Xid than 
in either of the two 6tk mutant animals generated by gene 
targeting. However, the severity of immunoglobulin defi- 
ciency also was found to be variable with respect to the 
two different genetic backgrounds on which the Xid muta- 
tion was analyzed (Figure 5). 
Defective Proliferation of Bfk-Deficient B Cells 
To assess the capacity of 6tk mutant B cells to respond 
to mitogenic signals, purified splenic Btk-PH-/RAG2-‘-, 
Bfk-Kin-IRAGP-‘-, Xid, and normal B cells (generated by 
injecting normal ES cell into RAG2’- blastocysts) were 
treated with anti-IgM and different concentrations of LPS. 
Flow cytometric analyses, after 12 hr of anti-IgM or LPS 
treatment, demonstrated the induction of the expression 
of early activation markers including CD69 and IL-2Ra on 
both normal and mutant B cells (data not shown). Measure- 
ment of proliferation byquantitating [3H]thymidine incorpo- 
ration after 60 hr of anti-IgM treatment indicated that Bfk- 
PH-, B&kin-, and Xid B cells did not proliferate compared 
with normal B cells (Table 4). Similarly, the proliferative 
response of Btk-PH-, B&-kin- B cells to LPS treatment 
was comparable to that of Xid and was significantly lower 
than that of normal B cells, particularly at lower concentra- 
tions (Figure 6). In contrast, phorbol ester and ionomycin 
stimulation of Btk-PH- B cells resulted in proliferative re- 
sponses comparable to those of normal B cells (Table 4). 
In a separate set of experiments, purified splenic B cells 
from Bfk-kin-IGL mice also were compared with those of 
normal littermates or CBA/CaHN (Xid, Jackson) mice for 
responsiveness to anti-IgD-dextran treatment or anti- 
CD40 treatment with or without added IL-4. Anti-lgD-dex- 
tran has been shown to be a stronger stimulator of B cells 
than soluble anti-IgD or anti-IgM (Mond et al., 1983; Mand- 
ler et al., 1993), while IL4 enhances the survival of B cells 
and induces proliferation when used as costimulant with 
B cell receptor or CD40 stimulation (Howard et al., 1982; 
Gold and Defranco, 1994; reviewed by Noelle and Show, 
1992). Responses to anti-IgD-dextran and CD40 ligation 
were diminished in Bfk-kin-IGL compared with control 6 
cells and were similar to those of Xid B cells; however, 
the stimulatory effect observed in the mutant cells was 
enhanced by IL-4. Our finding with the Xid cells are in 
accord with those of a previous report that Xid B cells show 
- 
some proliferation in response to sepharose-conjugated 
anti-immunoglobulin antibodies (Mond et al., 1983) and 
defective response to anti-CD40 antibodies (Hasbold and 
Klaus, 1994). 
Defective Humoral Immune Responses 
in Bfk-Deficient Mice 
To evaluate TI-II responsiveness, Brk-PH-/RAG2-‘-, nor- 
mal ES cell-derived RAG2-I- chimeric mice and CBA/N 
mice were immunized with the TI-II antigen trinitrophenol 
(T’NP)-Ficoll, and TNP-specific serum antibody titers were 
measured by ELISA. The results showed that Bt/r-PH-I 
RAG.?- chimeric mice and Xid mice (as previously de- 
scribed: Scher et al., 1975; reviewed by Scher, 1982) did 
not respond to this TI-h-dependent antigen (Figure 7A). 
In another set of experiments, germline Bfk-kin- mutant 
and CBA/N mice were also found to be unresponsive to 
immunization with TNP-Ficoll (Figure 79). 
To investigate TD responses in Btk-PH-/ftAG2-‘-, 6% 
Kin-/ffAG2-‘- chimeric mice, Btk-kin-IGL, Xid mice and 
normal control mice were challenged with optimal doses 
of the TD antigen TNP-keyhole limpet hemocyanin (KLH) 
and primary and secondary antibody responses to TNP 
and KLH were measured by ELISA. The primary antibody 
responses to both TNP and KLH were poor in all the Bfk- 
defective animals for all tested isotypes (data not shown). 
On the other hand, the secondary TNP-specific responses 
were relatively normal with respect to levels of total anti- 
gen-specific immunoglobulin, IgGl, IgGPa, and lgG2b, al- 
though antigen-specific IgM and lgG3 levels were still sig- 
nificantly reduced (Figure 8). Carrier (KLH)-specific total 
immunoglobulin, IgGl, IgG2a, and IgGPb levels were also 
comparable between mutant and normal animals (data not 
shown). The TNP-KLH responses observed in the Btk- 
deficient mice are consistent with those previously re- 
ported for Xid mice (Figure 8; Scher et al., 1979; Boswell 
et al., 1980). 
Discussion 
Effects of Bfk Null Mutations in Mice 
To test directly whether Btk deficiency results in an XLA- 
or Xid-like phenotype and to elucidate the role of Btk in 
B cell development and function, we have introduced two 
different mutations into the Btkgene in murine ES cells and 
assayed their effects on general development, lymphocyte 
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development, and B cell function. Both mutations were 
designed to eliminate specific functional domains of Btk 
(the PH and kinase domains); however, both appeared to 
result in the general absence of expression of any detect- 
able immunoreactive Btk protein and, thus, apparently 
represented null mutations. Our analyses of these intro- 
duced 13fk mutations clearly establish a role for this tyro- 
sine kinase in B cell development and function. However, 
the studies also demonstrate that complete elimination of 
Btk function did not result in the severe early B lymphocyte 
developmental arrest attributed to Btkmutations in human 
XLA. Rather, Btk-deficient mice had a murine Xi&like phe- 
notype that manifests mainly as defects in peripheral B 
cell responses and populations. In addition, the phenotype 
of mice deficient for Btk in their germline appeared identi- 
cal to that of chimeras generated from Btlc ES cells via 
RAGP-deficient blastocyst complementation; this shows 
that Bfk has no obvious role in cells other than those of 
the B lineage. 
Signaling Defects in B Lineage Cells 
of Btk-Deficient Mice 
Pre-B cells express a surface molecule that is composed of 
the lgp heavy chains plus the h5 (Sakaguchi and Melchers, 
1986) and Vpre-~ (Kudo and Melchers, 1987) surrogate light 
chains(Karasuyamaetal., 1993; TsubataandReth, 1990). 
This complex is thought to generate signals that are in- 
volved in the pro-B to pre-B cell transition (Takemori et 
al., 1990). Correspondingly, inactivation of the 15 gene 
leads to a developmental block at the pre-B cell stage, 
which resembles that observed in XLA patients (Kitamura 
et al., 1992). In this context, Btk was found to be constitu- 
tively phosphorylated in murine pre8 cells (Aoki et al., 
1994), leading to the suggestion that it may have a role 
in signaling from the pre-B cell receptor (Aoki et al., 1994). 
Our current results show that Btk is not essential for gener- 
ating the signals necessary for the various transitions ob- 
served in early murine B cell development, as we do not 
see a major early B cell developmental block in Btk defi- 
cient animals. In fact, the most obviousdifference between 
the BM B cell profiles of Btk-deficient and normal mice is 
the lack of recirculating mature B cells, which most likely 
reflect Bcells selected in the periphery(Kantoret al., 1995; 
Allman et al., 1992,1993). However, as wedo see asmall, 
but apparently significant, increase in the size of the pro-B 
cell population in R/r-deficient animals, it remains possible 
that Btk does play some role in generating signals involved 
in the transition from the pro-B to pre-B cell. 
The mature B cell receptor (BCR) complex is composed 
of two immunoglobulin heavy chains (p or&) and two immu- 
noglobulin light chains plus the invariant Iga and IgP 
chains that are involved in signal transduction (Campbell 
and Sefton, 1992; Burkhardt et al., 1991; Venkitaraman 
et al., 1991). Cross-linking of IgM on normal splenic B cells 
induces early activation markers (e.g., CD69 and IL-2Ra), 
followed by induction of DNA synthesis and proliferation 
(Testi et al., 1989; reviewed by Pleiman et al., 1994; Weiss 
and Littman, 1994; Janeway and Bottomly, 1994). Cross- 
linking of &k-deficient B cells did not induce DNA synthe- 
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Normal Xid X/dHHW Elk-Kin- Btk-Pti 
Normal Xid XIIYHHW Btk-Kin* Btk-PH Normal Xid X~#HHW Btk-Kin- Btk-PH 
Normal Xid X&‘HHW &k-Kin- Btk-PH- 
lgG2b 
1000 IgGl 
100 
1CQll 
W 
WI 
1 
Normal Xid XidHHW Stk-Kln- Btk-PH- 
Figure 5. Decreased Serum lmmunoglobulin Levels in &k-Deficient Mice 
Serum immunoglobulin levels in normal littermates (Bfk-kintn), Xid; (CBAICaHN.Xid/J, Jackson Laboratories) XidlHHW; (CBA.Xid/HHW, Wortis 
et al., 1982); and 6tk-PH~/RAG24- somatic chimeras were screened by ELISA for immunoglobulin isotypes. 
sis or proliferation, but still induced early activation marker 
expression. Therefore, some IgM-triggered events appear 
to require Btk as a downstream effector, while others do 
not. Btk-deficient cells also had a greatly diminished prolif- 
erative response to anti-IgD-dextran stimulation compared 
with normal cells, implicating Btk in signaling through the 
IgD BCR as well. However, some proliferation was ob- 
served in response to this treatment. Conceivably, the pro- 
longed and extensive surface immunoglobulin cross- 
linking generated by immobilized anti-immunoglobulin, 
which leads to activation of tyrosine kinases by frans- 
phosphorylation and recruitment of effector molecules 
(reviewed by Pleiman et al., 1994), can stimulate B cell 
proliferation through a non-Btk-dependent pathway. Btk 
phosphorylation and activation have been shown to occur 
following BCR cross-linking but with delayed kinetics rela- 
tive to that of several BCR-associated nonreceptor PTKs 
(Aoki et al., 1994; Saouf et al., 1994; reviewed by Pleiman 
et al., 1994). As several of the latter PTKs (e.g., Fyn, Lyn, 
and Hck) specifically interact with Btk, it has been sug- 
gested that Btk may function downstream from them in 
BCR signaling (Cheng et al., 1994). In this context, it will 
be of interest to determine the relative dependence of Btk- 
dependent and independent signaling events on the activi- 
ties of the putative upstream PTKs. 
Btk B cells showed deficiencies in additional signaling 
pathways. Thus, treatment of Btk- B cells with anti-CD40 
antibodies did not lead to the strong proliferative response 
observed in normal cells. Furthermore, Bfk cells did not 
respond well to LPS treatment, exhibiting significant prolif- 
eration only at high doses. Significantly, LPS-induced sig- 
naling has been shown to differ from that of the BCR in that 
it involves a protein kinase C(PKC)-independent pathway 
(reviewed by Klaus, 1988; Sigal and Dumont, 1992). Ex- 
pression of early activation markers was observed in re- 
sponse to both of these signaling pathways. Thus, 5fk is 
not essential in early activation of B cells as induced by 
signaling through either the BCR or by polyclonal mito- 
gens, but is required for proliferative responses in the 
context of all of these pathways. As phorbol ester and 
ionomycin stimulation of Bfk B cells resulted in normal 
proliferative responses, it further seems that Btk functions 
upstream of PKC activation and calcium mobilization in 
the affected pathways. Finally, defective signaling in Btk 
mice was also manifested by failure to mount a response 
to a classical TI-II antigen and a reduced primary re- 
sponse, but relatively unaffected secondary response, to 
a classical TD antigen. 
A potential signaling defect in Btk mice is also sug- 
gested by the marked reduction of CD5 (Bla) cells. Ab- 
sence of CD5+ B cells was also noted in vav’- mice (Zhang 
et al., 1995; Tarakhovsky et al., 1995). Notably, the var’- 
mice also have defective signaling through their BCR but, 
unlike BW mice, appear to respond relatively normally 
through the LPS and CD40 pathways. The differences in 
signaling responses in Btk- and vav-deficient B cells sug- 
gests a required role for Btk that is broader than vav with 
respect to B cell signaling pathways. However, the com- 
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Figure 8. Secondary Antibody Response to TD Antigen TNP-KLH Im- 
munization in Btk-kin-/GL, Normal Littermates, and CBA/N Mice 
Serialdilutionsofserum WereanalyzedforTNP-specificimmunoglobu- 
lin isotypes by ELISA. Results are expressed as OD405 of anti-isotype- 
specific ELISA using TNP-bovine serum albumin as capture reagent. 
A representative experiment is shown; the same results were obtained 
with three mice in each group. 
of responding to TI-II antigens, although some cells do 
mature to antibody-secreting plasma cells (reviewed by 
Conley, 1985). The murine Xicf defect, on the other hand, 
does not have a severe early impairment in B cell develop- 
ment but does have similar defects in peripheral B cell 
activation and function as observed in XLA. In all aspects, 
the phenotype of Bflc mice is essentially identical to that 
of Xid mice, unequivocally proving that lack of Btk function 
can result in an Xid phenotype. This is striking because 
Btlc mice do not express any detectable Btk gene prod- 
ucts, while Xid mice express Btk mRNA and intact protein 
kinase activity (Rawlings et al., 1993). Therefore, the Btk 
point mutation attributed to the Xid defect apparently gen- 
erates the same loss of function phenotype as complete 
ablation of Btk protein synthesis. In this context, it is possi- 
ble that the Xid mutation disrupt8 a functional domain(s) 
required for all Bt/r function or, conversely, lead8 to the 
generation of a protein with a dominant-negative activity. 
The XLA phenotype was suggested to result from muta- 
tions of the Btk protein, which eliminated all function or 
at least functions required for early B cell development 
(Thomas et al., 1993; Rawlings et al., 1993). However, 
this possibility was challenged when the same amino acid 
mutated in murinexid was found mutated in a man (Arg28His) 
(de Weers et al., 1994), but in association with the typical 
XLA phenotype. This finding led to the notion of a less 
stringent requirement for Btkfor early murine B cell devel- 
opment than that of humans. However, even in humans, 
subjects carrying the same Btk mutation may present a 
variable phenotype, and the characterization of XLA the 
phenotype tends to be biased by those who show severe 
clinical symptoms. Another case of such variability was 
recently reported in case of IL-2R(y) chain knockout and 
human XSCID (Cao et al., 1995). These observations raise 
the possibility that other genetic factors, not linked to the 
Brk gene, may affect the phenotypic severity of the muta- 
tion. Indeed, we note that the Xid mutation confers a nota- 
bly less severe B cell defect when bred into the genetic 
background of C57BL/6 mice (Tables 1, 2, 3). Quite con- 
ceivably, genetic backgrounds might be found that further 
enhance the setierity of the murine mutations or reduce 
the severity of some human mutations. However, our find- 
ings do not rule out the additional possibility that some 
mutations of Btk may result in dominant-negative proteins, 
which could cause a more severe phenotype than com- 
plete lack of Btk protein (Conley et al., 1994). 
In any case, it appears that Btk function is accompanied 
in mice by a compensatory mechanism that operates dur- 
ing early B cell development to rescue B cell maturation. 
One possible mechanism is a PTK that substitutes for Btk 
activity. Another is the specific spatio-temporal expres- 
sion of a cytokine or its receptor (i.e., a factor produced 
by murine, but not human, stromal cells or T cells) that 
can mediate the transition of precusors to mature B cells 
in mice, obviating a stringent requirement for Btk. In this 
context, when the xid and nude (a mutant mouse strain 
with a severly deficient thymus) defects are expressed 
together, B cell development is blocked at the pro-6 stage 
(Karagogeos et al., 1986). This phenotype resembles the 
block in B cell development of human XLA. The nude de- 
fect is not mediated at the level of stromal cells (Dong and 
Wortis, 1994). In fact, Xid BM cells do not repopulate the 
periphery of thymectomized mice unless T cells are pro- 
vided (Sprent and Bruce, 1984). The gene responsible 
for the nude defect, designated whn (Nehls et al., 1994), 
encodes a member of the winged-helix domain family of 
transcription factors and is specifically expressed in thy- 
mus and in skin. Together, these findings suggest that T 
cells or T cell-derived factor(s) play a role in facilitating 
the transition of pro-B cells to pre-B cells. 
Future Prospects 
Btk mice should enable studies of signal transduction in 
the absence of Btk. To elucidate the function of different 
potential functional domains of Btk in vivo, complementa- 
tion studies with mutated Btk transgenes can be per- 
formed. Crossing Btk- mice with knockout mice deficient 
for other candidate PTKs (e.g., Itk and Tee) or for particular 
cytokines or their receptors may provide insights into the 
molecular basis of potential compensatory mechanisms. 
Such mice ultimately may prove useful as a gene therapy 
model for XLA because they lack Btk as opposed to Xid 
mice, where presence of a mutated protein might compli- 
cate interpretation of results perhaps by acting as a domi- 
nant negative. 
Experimental Procedures 
Construction of Btk Targeting Vectors 
There are four ATG in-frame translation initiation sites located in exon 
2, 4, 8, and 7 of the Bfk gene. In vitro translation has shown that all 
these methionines can be used as start sites. To inactivate the PH 
domain specifically, exons 2 and 3 were replaced with the neo’ gene. 
If, in vivo, only the first initiation codon is used, this mutation will result 
in complete inactivation of Btk. To construct the BW-PH domain tar- 
geting vector, a Btk genomic clone containing 15.0 kb DNA fragment 
containing the Send of the Btk gene was isolated from a 129s~ DNA 
library using a genomic fragment, as probe, isolated by PCR amplifica- 
tion by Atk-1 and Atk-2 primers as described earlier (Sideras e1 al., 
1995). This clone containing most of the PH domain was used to make 
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the targeting construct to replace coding exon 2 and 3 with pGK-neo. 
A thymidine kinase (pGK-tk) gene was subcloned into Sall-Xhol sites 
of a modified SKII pBluescript from which Hindlll site of the polylinker 
was destroyed (tkpBS). A 5.5 kb Notl-BamHI fragment providing the 
5’flank of the construct, was subcloned into Notl-BamHI of this tkpBS. 
A 4.15 kb BarnHI-EcoRI fragment, containing the 3’ flank of the con- 
struct, was isolated by BamHl and partial EcoRl digestion and inserted 
between the 5’ flank and pGK-fk. Finally, pGK-neo was inserted as 
a Hindlll-BamHI fragment in between the two flanking sequences to 
generate the final targeting construct (Figure 1A). The construct was 
linearized with Notl prior to transfection into CCE ES cells. 
To construct the kinase domain targeting vector, an 8.0 kb BamHl 
fragment containing the entire kinase domain was subcloned into the 
above described tkpBS. Two Hindlll fragments (1.2 and 1.0 kb) con- 
taining exons 12 and 13 were deleted and replaced by pGK-neo to 
give the targeting construct (Figure 1 A, right). The construct was linear- 
ized with Notl prior to transfection into Jl ES cells. 
Generation of Bfk Mutant ES Cell Lines and Mice 
For the construction of Bfk-PH- ES cell lines, approximately 2 x 10’ 
CCE embryonic cells were transfected with 20 ug linearized construct 
by two pulses at 300 V and 70 pF in phosphate-buffered saline (PBS). 
Selection for growth in the presence of G418 (GIBCO) and gancyclovir 
(Sigma) was done as previously described (Shinkai et al., 1992). 
Screening for mutant ES cell clones was done by Southern blotting 
of Hindlll digested DNA from approximately 750 clones and hybridiza- 
tion to a 700 bp Pvull fragment located outside the construct. The 
endogenous fragment is 12 kb and the targeted fragment is 9.0 kb. 
Three mutant CCE clones were obtained, subcloned, and used for 
generation of chimeric mice. 
For the construction of &k-kin- ES cell lines, approximately 2 x 
IO’Jl embryonic cells were transfected with 25 ug linearized construct 
by a single pulse at 400 V and 25 trF in PBS. Selection for growth 
in the presence of G418 (GIBCO) and gancyclovir (Sigma) was as 
previously described (Shinkai et al., 1992). Screening for mutant ES 
cell clones was done by Southern blotting of EcoRl digested DNA from 
approximately 200clonesand hybridization to a700 bp BamHI-Hindlll 
fragment located outside the construct. Four mutant Jl clones were 
obtained and subcloned and two of the clones were used for injection 
into blastocysts from C57BU6 for germline transmission. Therefore, 
the mice (Efk-/dn/GL) analyzed have a mixed genetic background 
comprised of both 129s~ and C57BU6. 
To obtain the mice chimeric for the RAG.!P locus and a mutant Btk 
allele, two of the independent Efk-PH- (CCE cells) and Btk-kin- (Jl 
cells) subclones were injected into blastocysts from RAGPdeficient 
mice (which are of the mixed genetic background: 129Sv/C57.BU6) 
and transplanted into foster mothers (BG/CBA) as described (Chen et 
al., 1993). Thus, the CCE-Btk-PH-IRAGZ-‘- and Jl-Btk-kin-/RAG2 
chimeric mice have a mixed genetic background of 129SvlC57.BU6. 
Mice 
Normal littermates (Btk-XY sib of a X’ Y mouse) and mutant XM Y, 
were bred at Children’s Hospital, Boston, and UmeH University, lfmei, 
Sweden. CBAlNcaHN (XxdY) from Jackson Laboratories, CBA.xid/ 
HHW (Wortis et al 1962) and C57BU6.Xid males obtained from J. 
Kenney at National Cancer Institute were compared. 
Flow Cytometry Analysis 
Single cell suspensions from BM. spleen, thymus, lymph node, and 
peritoneal exudates from normal, Xid, RAG2-‘-, Brk-PH-IRAGP-‘+, and 
Btk-kin-IRAGP chimeras were prepared and stained by standard 
methods (Parks et al., 1986) using specific antibodies to lymphocyte 
cell surface markers. Cells in the lymphocyte gate by light scatter were 
analyzed at Howard Hughes Medical Institute/Children’s Hospital on a 
FACScan (Becton Dickinson, Mountain View, California) using LYSYS 
software. For experiments performed with chimeric mice, the antibod- 
ies purchased from Pharmingen (San Diego, California) were the 
following: fluorescein isothiocyanate(FITC)-conjugated RA 3-682 
(B220/CD45R), CD43(S7), AMS 9.1 (IgD’), (IgM’), phycoerythrin(PE)- 
conjugated DS-1 (IgMa), (B220/CD45R; Figure 3A), CD5. 
FACS analysis of 9- to 13-week-old Et/t-kinn (germline mutant 
mice), their normal littermates (Btk-kin+? and Xid(CBA/NcaHN) mice 
were performed using the methods and reagents described previously 
(Parks et al., 1989; Kantor et al., 1992). Monoclonal antibodies conju- 
gates with fluorophores, as previously used (Wells et al., 1994) were 
purified, prepared, and used according tostandard procedures (Hardy, 
1986; Kantor et al., 1992). In brief, single cell suspensions were pre- 
pared in deficient RPM1 1640 and EDTA (1 mM) was added to the 
medium for staining in microtiter plates. BM cells were stained with 
CD43/S7(PE), B220/6B2(APC), and lgM/331 (FITC), or lgM/331(TR-AV). 
All experiments were done using 1 .O mg/ml propidium iodide to identify 
dead cells. Spleen cells were stained with IgD/1126(TR-AV), CD4/ 
GKI .5(PE), CD8/535(PE), CD5/537(APC). igM/331(FITC), and 82201 
6B2(APC). Peritoneal exudates were stained with lgM/331 (FITC), IgDl 
ll-26(TR-AV), Macl/M1/7O(APC), and CD5/53-7(APC). Cells were 
analyzed at the shared FACS facility at Stanford University on 
“Flasher,” an extensively modified dual laser (488 and 595 nm excita- 
tion) FACS II (Parks et al., 1986) (Becton Dickinson, Mountain View, 
California) interfaced with a VAX 6300 computer (Digital Equipment, 
Maynard, Massachusetts) running FACS/Desksoftware(Stanford Uni- 
versity, Stanford, California) (Parks et al., 1989; Moore and Kautz, 
1986). The probability contour plots contain an equal number of cells 
between each pair of contour levels. The number of lines in each 
region of the map is essentially proportional to the number of cells in 
that region. All plots presented here have 5% probability contours. 
B Cell Proliferation Assays 
To purify splenic B cells, single cell suspensions were treated with 
anti-Thy1 and guinea pig complement (Hawrylowicz et al., 1984) and 
enriched for live cells by lympholyte M. Adherent cells were depleted 
by incubating on a tissue culture plate (Nunc) at 37OC. B cell prepara- 
tions were typically 85% pure for Xid (CBA/CaHN-XidlJ) (Jackson Lab- 
oratories), Blk-PH-, and Btk-kin-, and 95% B220+ for normal mice as 
assayed by FACS analysis. Cells were cultured at I@/100 ml in RPM 
1640 supplemented with 10% FCS, 100 U/ml penicillin/streptomycin, 
50 nM 2-ME, and 2.0 ug/ml goat anti-mouse IgM (Southern Biotechnol- 
ogy Associates), 20 nglml anti-IgD-dextran (Mandler et al., 1993) 2.0 
uglml anti-CD40 (Serotech), and several concentrations of LPS as 
indicated in the legend to Figure 6. For optimal B cell proliferation, 
conditioned supernatantsfrom IL+transfected cells (Karasuyama and 
Melchers, 1988; Luzkar et al., 1988) was added, where indicated. DNA 
synthesis was assayed by pulsing the cultures with 1 .O uCi ISH]thymi- 
dine/well at 60 hr and incubated for additional 6-8 hr, harvested, and 
counted on a scintillation counter. All assays were done in triplicates. 
lmmunlzatlons 
To measure the thymus-independent immune responses, Sfk-PH-/ 
ffAG2-‘- and Bfk-Kin/RAG2-‘- chimeric or Efk-Kin-/GL mice were im- 
munized with 10 ug TNP-Ficoll (gift of Dr. J. Inman, National Institutes 
of Health, Bethesda, Maryland) in PBS was injected intraperitoneally. 
The serum was analyzed at day 7 for TNP-specific total immunoglobu- 
lin antibodies by ELISA using TNP-Ficoll-coated plates. To measure 
the thymus-dependent immune responses, chimeric or germline mu- 
tant mice were immunized with 100 ug TNP-KLH precipitated with 
alum and injected intraperitoneally together with 1Og Bordetella pertus- 
sis (gift of Dr. A. Abbas). A booster dose of 60 pg of antigenin PBS 
was given at day 14. For the analysis of secondary immune responses, 
the serum was analyzed for isotype-specific anti-KLH or anti-TNP anti- 
bodies by ELISA after day 7 of booster dose. The plates were coated 
with TNP-OVA, or KLH (100 uglml). 
ELISA Assays 
lmmunol 1 plates (Dynatech) were coated with 5 ug/ml of isotype- 
specific rabbit or goat anti-mouse antibodies. Diluted serum sam- 
ples were incubated in the plates and revealed by alkaline phospha- 
tase-labeled secondary antibody. The antibodies were purchased 
from Southern Biotechnology Associates Incorporated, Birmingham, 
Alabama. 
DNA Probes, Southern, and Northern Blottlng Analysis 
For Southern blot analysis, DNA was prepared, restriction digested, 
electrophoresed, blotted on to zeta probe membranes using standard 
methods. The probe for detection of Bfk-PH knockout allele was a 
700 bp Pvull fragment from the 5’-end of the Etk gene containing exon 
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4 (62 bp) and sequences from intron V (Sideras et al., 1995). The 
probe for detection of Efk-kin knockout allele was a 700 bp Hindlll- 
BamHl fragment from the &and of the St/r gene containing sequences 
from intron 18 (Sideras et al., 1995). 
For Northern blot analysis, 15 ng of cytoplasmic RNA was electro- 
phoresed in a 1.2% formaldehyde agarose gel, transferred to 6 probe 
membranes using standard methods. The probe used for the detection 
of S-end sequences in Bfk transcript was a 1.5 kb EcoRl fragment 
from the 5’-end of the St/r cDNA containing the coding sequences up 
to the kinase domain. The 3’-end sequences in the Brk transcript were 
detected with a 1.4 kb EcoRl fragment from the 3’-end of the BNC cDNA 
that contains the coding sequences of the kinase domain and the 3’ 
UTR. (Sideras et al., 1995) and neo’ gene sequences were detected 
with a 800 bp Pstl-Pstl fragment of the neo’ gene. 
Generatlon of A-MuLV-Transformed Cell Lines 
A-MuLV-transformed pre-B cell lines were established as described 
by Rosenberg and Baltimore (1976). For the generation of Bt/r-/in- 
A-MuLV-transformants, BM cells from Brk-kinlGL mice were infected 
with A-MuLV and plated in soft agar; individual colonies were picked, 
transferred to liquid medium, and expanded. Bf/r-PH- cell lines were 
derived from BM of chimeric mice made by injection of Bfrr-PH- 
ES cells into RAG2’- blastocysts. Chimeric mice were identified by 
screening peripheral blood samples by flow cytometry for the presence 
of mature T and B cells, indicating ES cell contribution to the lympho- 
cyte compartment. BM cells from chimeric mice were subsequently 
infected with A-MuLV and plated as above. Individual colonies were 
expanded in 24-well plates, screened by PCR for the presence of the 
RAGP’+ genotype, indicating ES derivation, and selected cell lines 
were expanded. The Srk-PH- or St/r-Kin genotypes of all cell lines 
were confirmed by Southern blotting analysis (data not shown). 
Protein Analysis 
Rabbit polyclonal anti-Btk antibodies used in immunoprecipitation and 
Western blot analysis were specific for the unique N-terminal region 
of Btk and for the last 15 aa (645-659) of the C terminus (a gift of Dr. 
0. Witte) of Btk, respectively. Antibodies were immunoaffinity purified. 
lmmunoprecipitation was performed on Abelson-transformed Et/r-kin 
A-MuLV and RAGP A-MuLV transformants (as a positive control) 
and T cell line DO10 (as negative control). Cells (IO x 10s) for positive 
and negative control cell lines and 30 x lo6 cells for Bf/r-kin- cell 
line were labeled with 1.0 PCi, 10 x 10’ cells of [“Sjmethionine and 
cysteinefor 15 min in RPM1 medium lacking methionine and cysteine. 
After labeling, cells weresolubilized in lysis buffer containing 1% Noni- 
det P-40, Tris-HCI (pH 7.5) 150 mM NaCI, and protease inhibitors, 
aprotinine, leupeptin, ABSF, 1 mM PMSF, and incubated with 10 pg 
antibodies for 4 hr at 4OC. The immune complexes were recovered 
by protein A-Sepharose and analyzed on SDS-PAGE and autoradiog- 
raphy. For Western blot analysis, lysates of 3-5 x lo8 cells were 
denatured and separated on SDS-PAGE and transferred to immobilon 
(Millipore) membrane. The filter was blocked by 10% milk in TBST 
for 4 hr and incubated with 1:2000 diluted anti-N-terminal or anti- 
C-terminal antibodies for 2 hr. The antibody-reactive proteins were 
visualized by horseradish peroxidase-conjugated anti-rabbit antibod- 
ies and enhanced chemiluminescence light-emitting detection system 
(Amersham). 
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